Header Logo

Connection

SHAWN HIRSCH to Adrenergic alpha-2 Receptor Agonists

Back to Details
This is a "connection" page, showing publications SHAWN HIRSCH has written about Adrenergic alpha-2 Receptor Agonists.
SHAWN HIRSCH
Connection Strength
0.221
Adrenergic alpha-2 Receptor Agonists
  1. Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo-controlled crossover laboratory study. Am J Addict. 2025 Jan; 34(1):7-14.
    View in: PubMed
    Score: 0.221
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.